Neue Führung für Danone in Deutschland, Österreich und der Schweiz

Frankfurt (ots)

Der langjährige Danone-Manager Jean-Yves Krummenacher übernimmt ab November 2026 als General Manager DACH die Geschäftsführung von Danone in Deutschland, Österreich und der Schweiz. Er folgt auf Richard Trechman, der Danone verlassen wird, um eine neue berufliche Herausforderung außerhalb des Unternehmens anzunehmen.

Jean-Yves Krummenacher verfügt über mehr als 25 Jahre internationale Erfahrung bei Danone und hat in verschiedenen Führungsfunktionen die Entwicklung des Unternehmens entscheidend mitgeprägt. Zuletzt war der Schweizer und französische Staatsbürger als Global Chief Procurement Officer für die globale Beschaffungsstrategie von Danone verantwortlich und führte gleichzeitig das weltweite Handels- und Beschaffungsgeschäft als Geschäftsführer. Zuvor bekleidete Krummenacher verschiedene Führungspositionen in Europa, Asien und Lateinamerika in den Bereichen Vertrieb, Einkauf oder Nachhaltigkeit.

In seiner neuen Funktion wird Krummenacher die Weiterentwicklung des DACH-Geschäfts verantworten und die Wachstumsstrategie von Danone in der Region konsequent vorantreiben. Sein Fokus liegt auf der Stärkung der Marktposition von Danone, der Weiterentwicklung des erfolgreichen Markenportfolios, sowie der Förderung von Innovationen, die den Bedürfnissen von Verbraucher:innen gerecht werden, begleitet von dem Anspruch, eine Unternehmenskultur zu fördern, in der Menschen wachsen und sich weiterentwickeln können. Nicht zuletzt über den Ausbau partnerschaftlicher Kundenbeziehungen möchte er die Mission des Unternehmens vorantreiben, die Gesundheit so vieler Menschen wie möglich durch Ernährung zu fördern.

Krummenacher zu seiner neuen beruflichen Herausforderung: "Mit unseren gesundheitsorientierten Kategorien und starken Marken verfügen wir über beste Voraussetzungen, einen Wert für unsere Kunden und Konsument:innen in Deutschland, Österreich und der Schweiz zu schaffen. Ich glaube fest an die Kraft enger Partnerschaften entlang der gesamten Wertschöpfungskette, um gemeinsam Mehrwerte zu schaffen und nachhaltiges Wachstum zu beschleunigen."

Jean-Yves Krummenacher wird Teil des regionalen Führungsteams für Europa, den Nahen Osten und Afrika (EMEA) sein und an Pablo Perversi, Präsident EMEA, berichten. Krummenacher ist verheiratet und hat drei Kinder.

Pressekontakt:

Original-Content von: Danone DACH, übermittelt durch news aktuell

The 100% Smart Business Class airline will introduce up to five weekly flights in

Spring 2027, connecting New York with Düsseldorf and the Rhine-Ruhr region 

NEW YORK, Sept. 7, 2026 /PRNewswire/ -- La Compagnie, the 100% Smart Business Class airline, today announced plans to launch nonstop service between New York's Newark Liberty International Airport (EWR) and Düsseldorf Airport (DUS) in Germany, beginning in Spring 2027.

Operating up to five times weekly, the route will connect New York with Düsseldorf and the Rhine-Ruhr region, one of Europe's most important economic centers, providing a new premium option for transatlantic business and leisure travel. Upon launch, La Compagnie will be the only airline to offer nonstop service between New York and Düsseldorf.

The new service responds to clear demand in North Rhine-Westphalia, a globally connected economic region with deep and longstanding ties to the U.S. Düsseldorf is one of the world's leading trade show destinations and a hub for international companies across fashion, telecommunications, life sciences, professional services and advanced manufacturing. More than 24,000 international companies are based in the state, including approximately 1,700 U.S. companies. The United States is also North Rhine-Westphalia's most important non-European export market, underscoring the value of direct service to New York.

As the largest airport in Germany's most populous federal state, Düsseldorf Airport combines a strong local market with accessibility, efficiency and a premium airport environment. For leisure travelers, Düsseldorf offers art, architecture, shopping and gastronomy, while also serving as a convenient gateway to the Rhineland's historic towns, vineyards, castles and renowned river-cruise itineraries along the Rhine. The airport's proximity to the Netherlands and Belgium also makes the route an attractive option for travelers from neighboring regions.

"Düsseldorf represents a natural next chapter in La Compagnie's development," said Christian Vernet, President and CEO of La Compagnie. "At the heart of one of Europe's most dynamic economic regions, with strong international businesses and longstanding ties to the United States, North Rhine-Westphalia is well suited to our unique all-business-class model. We look forward to welcoming travelers from the region on board, while also offering our American clientele a new and convenient gateway to Germany."

"This connection is an exceptional fit for Düsseldorf and North Rhine-Westphalia," explains Lars Redeligx, CEO of Düsseldorf Airport. "The United States is a key market for our state's economy, and New York is one of the world's most important travel destinations. La Compagnie is bringing a clearly defined product to our airport: nonstop, comfortable and designed for people who want to cross the Atlantic efficiently and in a relaxed way. The fact that this offer, unique in Germany, is launching in Düsseldorf says a great deal about the strength of our airport and our catchment area."

NEW YORK–DÜSSELDORF SERVICE

Beginning in Spring 2027, La Compagnie will offer up to five weekly flights between New York and Düsseldorf during the summer season aboard a new Airbus A321neo LR. Schedule details and tickets are now available at LaCompagnie.com, through the airline's call center and via travel advisors.

A SEAMLESS, ALL-BUSINESS-CLASS JOURNEY

The Düsseldorf route will offer La Compagnie's signature end-to-end experience, from lounge access at departure to its intimate, exclusively business-class cabin. At Düsseldorf Airport, passengers will have access to the DUS Sky Lounge in Pier C. In Newark, La Compagnie guests can access Lounge&Co, the airline's recently renovated and dedicated private lounge.

Aboard La Compagnie's Airbus A321neo aircraft, every seat converts into a fully flat bed. The experience also includes complimentary gate-to-gate unlimited high-speed Wi-Fi, state-of-the-art entertainment, a generous baggage allowance, seasonal menus created by renowned chefs and paired with French wines and Champagne, and amenity kits featuring Beau Domaine skincare, all designed to create a more enjoyable journey.

CONTINUED GROWTH ACROSS THE ATLANTIC

The Düsseldorf launch marks another significant milestone for La Compagnie, which has been redefining business-class travel since 2014. The airline currently connects Newark with Paris Orly, Nice Côte d'Azur and Milan Malpensa, and recently announced the extension of its New York–Nice service into the winter season for the first time.

La Compagnie's route expansion will be supported by the planned arrival of a third Airbus A321neo LR in 2027, followed by a fourth Airbus A321neo XLR in 2028. As part of its commitment to more responsible air travel, the airline is investing in quieter, more fuel-efficient aircraft designed to reduce CO₂ emissions by up to 30% compared with its previous-generation fleet, placing them among the most efficient aircraft available for transatlantic operations. The additions will also deliver greater range and operational flexibility, further advancing La Compagnie's long-term international growth while maintaining the distinctive all-business-class experience at the heart of its model.

ABOUT LA COMPAGNIE

Launched in 2014, La Compagnie is a French airline that has been reinventing business-class travel through a unique, personal approach. It has connected New York's Newark Liberty International Airport with Paris Orly since its founding, Nice since 2019 and Milan Malpensa since 2022. More than a premium carrier, La Compagnie offers a fresh vision of smart business-class travel for discerning travelers seeking a more refined experience.

Its current fleet of latest-generation Airbus A321neo aircraft is configured entirely in 100% Business Class, with just 76 seats in a 2-2 layout. This intimate cabin features fully lie-flat beds, an innovative entertainment system, complimentary unlimited high-speed Wi-Fi, gourmet seasonal dining created with renowned chefs and a generous baggage allowance. From the airport to arrival, travelers enjoy a seamless experience that includes lounge access at every airport, including the exclusive Lounge&Co private space at Newark.

For more information, visit LaCompagnie.com

IMAGES

High-resolution images are available for download HERE.

PRESS CONTACT

Anne-Cécile Blanchot

August Twenty Eight

[email protected]

Elena Bonaccorsi

Head of Marketing, Communication & Product | La Compagnie

[email protected]

SOURCE La Compagnie

Share this article

U.S. District Court Invalidates Kaneka's Ubiquinol Patent, Clearing the Way for Cocrystal Tech's CrysQnol™ in the U.S. Market

Judge Overturns Kaneka's '080 Patent for Lack of Utility and Enablement, Removing Legal Uncertainty for Customers and Partners

JIAXING, China, Sept. 7, 2026 /PRNewswire/ -- Cocrystal Technology (Jiaxing) Co., Ltd. ("Cocrystal Tech") today announced that the U.S. District Court for the Eastern District of New York has ruled in the company's favor in its long-running patent dispute with Kaneka Corporation, holding that the two patent claims asserted against Cocrystal Tech are invalid. In a Memorandum and Order issued September 2, 2026 in Kaneka Corp. vs. Cocrystal Technology (Jiaxing) Co., Ltd. et al., Case No. 1:23-cv-07483 (E.D.N.Y.), the Court found that Kaneka failed to meet the utility and enablement requirements of U.S. patent law, entered judgment in Cocrystal Tech's favor, and closed the case. As a result, Cocrystal Tech is entitled to continue to manufacture, market, and sell its reduced coenzyme Q10 (ubiquinol) ingredient, marketed under the CrysQnol™ trademark, in the United States without restriction under the invalidated patent.

Kaneka filed suit against Cocrystal Tech in October 2023 in the Eastern District of New York, alleging that Crystal QH® - Cocrystal Tech's flagship ubiquinol ingredient, now marketed as CrysQnol™ - infringed U.S. Patent No. 7,829,080 (the "'080 Patent"). The asserted claims cover compositions of reduced coenzyme Q10 containing any amount of reduced coenzyme Q11, a naturally occurring minor component found in CoQ10 materials. Although Cocrystal Tech stipulated that its product fell within the literal language of the asserted claims, it maintained throughout the litigation that the claims were invalid. Following nearly two years of fact and expert discovery, the Court agreed, finding on summary judgment that Kaneka's asserted invention was based on an untested hypothesis rather than a patentable invention. The Court further noted that even Kaneka's own inventors and expert witnesses could not explain, and had never studied, how or why coenzyme Q11 would have any stabilizing effect.

The ruling brings welcome finality to a dispute that has spanned nearly three years and removes a significant source of uncertainty for the U.S. nutraceutical industry. With the asserted patent claims invalidated, brand partners, formulators, CMOs and distributors can evaluate CrysQnol™ on its own technical and commercial merits - including stability, bioavailability, formulation flexibility, supply security, and cost efficiency.

The decision also underscores years of investment in Cocrystal Tech's proprietary cocrystal stabilization technology, reinforcing the company's position as an innovator in the global ubiquinol ingredient market. "Our focus has never been on following an established path, but on solving difficult scientific problems through our own research and technology," said Dr. Xuefeng Mei, Founder of Cocrystal Tech. "We are pleased that the Court has recognized the importance of the issues at stake in this case. For us, the ruling marks not an endpoint, but an opportunity to bring our technology to more customers and continue innovating in the U.S. market".

Introducing CrysQnol™: The New Name for Cocrystal's Ubiquinol

In conjunction with this legal milestone, Cocrystal Tech - owner of the Crystal QH® trademark - has initiated the transition to its new CrysQnol™ brand, formalizing the rebrand across its global trademark matrix. Customers and partners can expect full continuity of formulation and specifications through the transition, with the CrysQnol™ brand now serving as the unified identity for Cocrystal's ubiquinol ingredient.

The favorable ruling comes as Cocrystal Tech continues to expand its portfolio of premium, science-backed nutritional ingredients. Built on the company's proprietary Cocrysta™ technology platform, Cocrystal Tech's ingredient lineup - including CrysQnol™, CurCutine™, Precitein™, and UroRenu™ - is designed to improve the stability, bioavailability, and performance of some of the industry's most in-demand nutraceutical compounds. Cocrystal Tech remains committed to protecting and growing its intellectual property portfolio and to investing in the research that differentiates its ingredients in an increasingly competitive global market.

About Cocrystal Tech

Cocrystal Tech is the world's first company to apply pharmaceutical-grade cocrystal technology to human nutrition. We are committed to creating higher-value nutrition solutions that deliver more with less.

We believe true innovation goes beyond advancing science. For us, it means making nutrition solutions more sustainable, more accessible, and more impactful for people everywhere. Our ingredients and formulations are now trusted across North America, Europe, and Asia-Pacific by leading brands and partners worldwide. For more information, visit www.cocrystaltech.com.

Media Contact:

Christina Huang, Marketing Director

Cocrystal Technology (Jiaxing) Co., Ltd.

[email protected]

SOURCE Cocrystal Technology (Jiaxing) Co., Ltd.

Share this article

GEEKOM Launches A5 2027 Edition Mini PC, Built for Productivity That Lasts

TAIPEI, Sept. 7, 2026 /PRNewswire/ -- GEEKOM, a leading global Mini PC brand, is redefining the productivity Mini PC with the launch of the A5 2027 Edition. Designed for all-day productivity, the new A5 combines dependable performance, long-term reliability and flexible expansion in a compact form.

Powered by the 8-core, 16-thread AMD Ryzen™ 7 7730U, the A5 2027 Edition is built for real-world productivity — from running 30+ browser tabs alongside video meetings and large spreadsheets to Photoshop, 2D design and light 4K editing. With up to 64GB of memory, 7TB of storage and four-display support, it gives professionals, creators and small businesses the flexibility to build a workspace around the way they work.

But productivity also depends on how long a PC can be trusted to perform. The A5 2027 Edition uses brand-new SSDs, a reinforced all-metal internal frame and multi-layer motherboard protection, and undergoes 339 validation checks covering durability, aging, thermals and more. Together with flexible memory and storage upgrades, this quality-from-the-inside-out approach gives GEEKOM the confidence to offer a three-year warranty and engineer its PCs for more than five years of service.

Reliability also means being ready when work does not stop. The A5 2027 Edition's IceBlast 3.0 cooling system combines a larger silent fan, copper heat pipe and dedicated copper plate to efficiently move heat away from critical components. Better thermal control reduces throttling and long-term heat stress, enabling stable 24/7 operation for offices, retail systems, digital signage and other always-on environments.

The A5 2027 Edition also brings AI into everyday productivity. It can serve as a personal AI assistant for research, writing, content creation and data analysis, while emerging agentic applications can automate more complex, multi-step workflows. With stable, always-on operation, the A5 2027 Edition can keep these AI workflows running in the background when needed — helping users get more done with less hands-on effort.

The A5 2027 Edition brings GEEKOM's vision of all-day productivity to life: built to do more, built to keep running and built to last. Best All-Day Productivity Mini PC. Cool・Silent・Stable.

The GEEKOM A5 2027 Edition is available now through GEEKOM's official website and Amazon.

SOURCE GEEKOM

Share this article

Truecaller expands enterprise suite; allows consumers to communicate with businesses in a tap

STOCKHOLM, Sept. 7, 2026 /PRNewswire/ -- Truecaller, the leading global platform for safe and trusted communication, today launched Post-Call Actions, a new capability that enables consumers to complete important tasks immediately when the call ends. The functionality is first rolling out to the high intent category of last-mile delivery companies, soon to be followed by use cases and customisable options supporting the big industry of banking, financial services and insurance. Post-Call Actions ensures a business call no longer ends with "we'll send you a link." It ends with getting the job done.

Post-Call Actions appear at the exact moment people are already paying attention: the instant when a verified business call ends. A branded action card appears automatically in Truecaller, and whatever the next step is, it becomes one tap away, no app to download, no link to hunt for, no queue to wait in.

For deliveries, the friction is familiar: a call arrives when you're at work or mid-commute—impossible to take, and by the time it's returned, the slot is gone. Or it is answered, but the same directions have to be repeated to yet another new agent. With post-call actions, customers can now instantly reschedule the delivery, confirm their availability, share precise location, or authorize a safe drop—directly in Truecaller.

For banking, financial services, and insurance customers, the stakes and the anxiety are higher. A call from a bank today could be genuine or a sophisticated impersonation scam. Because Post Call Actions only appear after Verified Business calls, customers can now act with confidence instead of second-guessing. From that trusted screen, they can pay dues, request a callback, complete a pending KYC step, or confirm a transaction, without hunting for a link that may or may not be genuine, at a time when impersonation fraud is at an all-time high.

For the businesses on the other end of the call, Post-Call Actions changes what a completed call means. Call performance has traditionally been measured by pick up rates. Now it can be measured by whether it was resolved—with the follow-through happening in the same trusted moment, on the same screen, instead of leaking away across SMS links, app downloads, and abandoned IVR queues.

"A phone call has been the most human way for a business to communicate with customers. But it usually ends with homework for them," said Priyam Bose, Global Head, GTM, Truecaller for Business. "Post-Call Actions resolve this. The delivery gets rescheduled, the bill gets paid, the KYC gets done, all in the same trusted moment, on the same screen, irrespective of the calls getting picked up or unanswered."

For more information, please contact:

Andreas Frid, Head of IR & Communication

+46 70 529 08 00

andreas.frid@truecaller.com 

About Truecaller:

Truecaller is the leading global platform for secure and reliable communication. Fraud and unwanted communication are commonplace in digital economies and emerging markets in particular. Our mission is to create reliable communication. Truecaller is a natural part of the daily communication of more than 500 million active users. Truecaller has been listed on Nasdaq Stockholm since October 8, 2021. For more information, please visit corporate.truecaller.com.

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

SOURCE Truecaller AB

Share this article

20 Jahre „Die große Maus-Show“: Jubiläums-Ausgabe mit Esther Sedlaczek und prominenten Gästen

Köln (ots)

Geburtstag mit der Maus: Am Samstag, den 12. September 2026, feiert „Die große Maus-Show“ um 20:15 Uhr ihr 20-jähriges Bestehen in einer besonderen Jubiläums-Ausgabe im Ersten. Unter dem Motto „Kinder fragen, Erwachsene staunen“ führt Gastgeberin Esther Sedlaczek durch einen Abend voller faszinierender Quizfragen, überraschender Experimente und prominenter Gäste.

Zu Gast sind: Annette Frier, Wincent Weiss, Klaas Heufer-Umlauf, Axel Prahl, Beatrice Egli und Till Reiners.

Was vor 20 Jahren zunächst unter dem Titel „Frag doch mal die Maus“ als einmalige Aktion gedacht war, entwickelte sich schnell zur festen Größe am Samstagabend im Ersten.

WDR-Unterhaltungschefin Karin Kuhn: „20 Jahre Maus-Show, das sind 20 Jahre öffentlich-rechtliche Samstagabend-Unterhaltung im allerbesten Sinne - für die ganze Familie. Mehr als 300 Kinder mit verrückten, überraschenden und lustigen Fragen, mehr als hundert originelle Experimente, die uns zum Staunen und Mitfiebern gebracht haben. Also: Viel Spaß, viel Wissen und ganz viel Maus!“

Esther Sedlaczek: „Was gibt es Schöneres, als zusammen mit der Maus, vielen neugierigen Kindern und tollen prominenten Gästen zu feiern? Wir lassen es krachen! In dieser ganz besonderen Jubiläumsausgabe.“

Kinderfragen, Experimente und glasklare Antworten

Dabei gibt es einen spannenden Rückblick auf die verrücktesten Experimente aus 20 Jahren Maus-Show. So wurden Autos mit Laubbläsern angetrieben oder Instrumente unter Wasser gespielt. Wer errät, wie diese Abenteuer ausgegangen sind?

Und auch ganz neue Fragen bringen die Promis zum Rätseln: „Ist es möglich, im Looping einer Achterbahn ein Eis zu werfen und wieder zu fangen?“, „wie viel Energie vergeuden Glühwürmchen beim Leuchten?“ und „warum klingt meine Stimme so tief, wenn ich einen Videoclip in Zeitlupe abspiele?“

Die glasklaren Antworten kommen, wie immer, von den Experten aus der „Sendung mit der Maus“: Siham El-Maimouni, Ralph Caspers und Christoph Biemann – für sie ist kein Rätsel zu groß und kein Experiment zu schwer.

Esther Sedlaczek: „Ich freue mich auch sehr auf zwei Könner-Kinder von damals, die inzwischen längst erwachsen geworden sind: Pianistin Laetitia Hahn und Wasserspringer Jaden Eikermann. Sie haben ihr Können erfolgreich zum Beruf gemacht und spannende Fragen für uns vorbereitet.“

„Die große Maus-Show“ ist eine Produktion des WDR in Zusammenarbeit mit ITV Studios Germany für die ARD. Die Redaktion liegt bei Michael Kerkmann (WDR).

Weitere Informationen zur Jubiläums-Ausgabe finden Sie auf der ARD-Themenseite: https://pressekits.ard.de/die-grosse-maus-show#jubilaeumsshow. Dort gibt es unter anderem die verrücktesten Experimente, die lustigsten Kinderfragen sowie weitere spannende Zahlen, Daten und Fakten aus den letzten 20 Jahren „Die große Maus-Show“. Bildmaterial finden Sie außerdem unter www.ard-foto.de

WDR Presselounge: www.presse.wdr.de

Pressekontakt:

WDR Kommunikation

Telefon: 0221 220 7100

E-Mail: kommunikation@wdr.de

Original-Content von: WDR Westdeutscher Rundfunk, übermittelt durch news aktuell

Sachsen-Anhalt hat den Wechsel gewählt - der Pharmastandort braucht Kontinuität

Berlin (ots)

Pharma Deutschland mahnt die Wahrnehmung wirtschaftspolitischer Verantwortung an

Pharma Deutschland und die in Sachsen-Anhalt ansässigen Pharmaunternehmen reagieren mit Sorge um den wichtigen Pharmastandort Sachsen-Anhalt auf das Ergebnis der Landtagswahl. Pharma ist international, sowohl was Wirtschaftsbeziehungen als auch Mitarbeiterinnen und Mitarbeiter angeht.

Dazu sagt Dorothee Brakmann, Hauptgeschäftsführerin von Pharma Deutschland: "Die Pharmabranche ist darauf angewiesen, die besten Köpfe ungeachtet ihrer Herkunft beschäftigen zu können. Nur in einem weltoffenen gesellschaftlichen Klima ist es möglich, dass dringend benötigte Innovationen und Arzneimittelgrundversorgung aus Deutschland kommen und die Gesundheitsversorgung der Menschen mit Arzneimitteln auch in Zukunft sichergestellt bleibt. Ohne diese Voraussetzungen ist die zukünftige Pharmaproduktion nicht nur erheblich erschwert, sondern auch neue Ansiedlungen und Investitionen unwahrscheinlicher. Sachsen-Anhalt hat den Wechsel gewählt, der Pharmastandort braucht Kontinuität."

_______________

Der Pharma Deutschland e.V. ist der mitgliederstärkste Branchenverband der Pharmaindustrie in Deutschland. Er vertritt die Interessen von rund 400 Mitgliedsunternehmen, die in Deutschland ca. 80.000 Mitarbeiterinnen und Mitarbeiter beschäftigen. Die in Pharma Deutschland e.V. organisierten Unternehmen tragen maßgeblich dazu bei, die Arzneimittelversorgung in Deutschland zu sichern. So stellen sie fast 80 Prozent der in Apotheken verkauften rezeptfreien und fast zwei Drittel der rezeptpflichtigen Arzneimittel sowie einen Großteil der stofflichen und dentalen Medizinprodukte für die Patientinnen und Patienten bereit. Unter www.pharmadeutschland.de gibt es mehr Informationen zu Pharma Deutschland.

Pressekontakt:

Ihre Ansprechpartner in der Pressestelle von Pharma Deutschland:

Hannes Hönemann

Leiter Abteilung Presse- und Öffentlichkeitsarbeit

T. +49 171 5618203

hoenemann@pharmadeutschland.de

Anna Frederike Gutzeit

CvD Presse- und Öffentlichkeitsarbeit

T. +49 170 4548014

gutzeit@pharmadeutschland.de

Geschäftsstelle Berlin

Pharma Deutschland e.V.

Friedrichstraße 134

10117 Berlin

Geschäftsstelle Bonn

Pharma Deutschland e.V.

Ubierstraße 71-73

53173 Bonn

Geschäftsstelle Brüssel

Pharma Deutschland e.V.

Rue Marie de Bourgogne 58

1000 Brüssel

www.pharmadeutschland.de

LinkedIn: https://www.linkedin.com/company/pharmadeutschland/

Original-Content von: Pharma Deutschland e.V., übermittelt durch news aktuell

ZDF-Programmänderung ab Woche 38/26

Mainz (ots)

Woche 38/26

Sa., 12.9.

Bitte neuen Ausdruck beachten:

17.35 ZDF.reportage (HD/UT)

Countdown im Norden

Mecklenburg-Vorpommern vor der Wahl

Film von Felix Krüger und Frank Engelmann

Deutschland 2026

Im Streaming: 12. September 2026, 17.35 Uhr bis 12. September 2031

(Bitte auch für die Wiederholung am So., 13.9., 5.00 Uhr beachten.)

Woche 39/26

Sa., 19.9.

Bitte neuen Ausdruck beachten:

17.35 ZDF.reportage (HD/UT)

Leben auf Achse

Pendler, Trucker, Monteure

Film von Friederike Lorenz

Deutschland 2026

Im Streaming: 18. September 2026, 06.00 Uhr bis 18. September 2031

(Bitte auch für die Wiederholung am So., 20.9., 5.00 Uhr beachten.

Woche 40/26

Sa., 26.9.

Bitte neuen Ausdruck beachten:

17.35 ZDF.reportage (HD/UT)

Bahnhofsviertel Frankfurt

Alltag, Drogen, Nightlife

Film von Inken Klinge, Susana Santina und Peter Theisen

Deutschland 2026

Im Streaming: 25. September 2026, 06.00 Uhr bis 25. September 2031

(Bitte auch für die Wiederholung am So., 27.9., 5.00 Uhr beachten.)

Woche 42/26

Sa., 11.10.

Bitte neuen Ausdruck beachten:

15.30 plan b: next BITE (HD/UT)

Gutes Essen geht auch günstig

Film von Philipp Kopka

Deutschland/Dänemark 2026

Im Streaming: 1. Oktober 2026, 10.00 Uhr bis 30. September 2031

("plan b: Proteine neu gedacht" verschiebt sich auf den 18.9.26, 15.30 Uhr)

Pressekontakt:

ZDF-Planung

Original-Content von: ZDF, übermittelt durch news aktuell

Ministry of Food and Drug Safety of Korea, Successfully Concludes 'GBC 2026,' Marking a Great Leap in Bio

– 5,600 participants from 19 countries discuss global bio innovation and the path forward –

– Strengthened global regulatory cooperation, with a total of 23 meetings held with overseas regulators and industry, including 5 regulatory cooperation meetings –

SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ -- This is an article published in The Korea Herald:

The Ministry of Food and Drug Safety of Korea (MFDS, Minister Oh Yu-Kyoung) announced that it has successfully concluded the "2026 Global Bio Conference (GBC)," held under the theme "The Great Leap in Bio, Accelerating Innovation" from Wednesday, 26 August to Friday, 28 August at the Grand InterContinental Seoul Parnas.

Now in its 12th edition, this year's GBC brought together approximately 5,600* participants — including regulatory authorities, pharmaceutical and biotech industry professionals, and academic experts in the biopharmaceutical field from 19 countries around the world. Together with 75 overseas experts, participants from Korea and abroad shared the latest technology and development trends in the bio field and global regulatory policy, and discussed innovation and future directions for a great leap in the bio industry.

* A total of 75 biopharmaceutical experts from 19 countries gave presentations, with approximately 5,600 participants from academia, industry and regulatory authorities attending online and offline (Advanced Biopharmaceuticals Policy and Quality Forum: 483; Vaccine Forum: 462; Recombinant Protein Products Forum: 591; and others)

In particular, this year's GBC strengthened regulatory innovation in step with advances in cutting-edge bio technology, while also deepening international regulatory cooperation through 5 cooperation meetings among regulatory authorities, 16 meetings between 9 domestic companies and overseas regulatory authorities, and 2 meetings between overseas companies and MFDS — supporting K-Bio's entry into the global market and expanding the cooperative network among regulatory authorities.

[Innovation] Accelerating the Great Leap in Bio through Advanced Technology and Regulatory Innovation

This year's GBC held wide-ranging discussions on the latest technology trends at home and abroad, and on corresponding regulatory response strategies, in step with fast-evolving innovative technologies such as artificial intelligence (AI) and advanced biopharmaceuticals, and with changes in the biopharmaceutical development environment.

In addition, through field-specific forums on vaccines, recombinant protein products and advanced biopharmaceuticals, along with a range of specialized programmes, the conference shared the latest R&D trends and approval/review case studies, and explored ways to build a reasonable regulatory environment so that innovative biopharmaceuticals can be developed swiftly, expanding treatment opportunities for patients.

"GBC Special: K-Bio Innovation Leaders Talk," which brought together companies leading Korea's bio industry, shared their experience and successful strategies in taking on global markets, and exchanged views on the innovation, challenges and future direction needed for K-Bio to lead the global market.

[Cooperation] Strengthening Cooperation among Regulatory Authorities and Supporting K-Bio's Global Expansion

Global regulators from Canada, Japan, Singapore, Vietnam, Malaysia and other countries shared their countries' approval and review systems, the latest policy trends, and cases of information exchange and joint cooperation among global regulatory authorities at the "Regulatory Workshop," and exchanged views on ways to strengthen international cooperation.

Regulatory authorities from Korea, the United States, Japan and Europe also discussed the current status and key issues of approval and review systems for recombinant protein products, as well as ways to cooperate on reviews.

In particular, at the joint workshop with Japan's regulatory authority — now in its 9th year — participants shared and discussed the latest review cases for a range of products incorporating advanced bio technologies, including the world's first approved induced pluripotent stem cell (iPSC) therapy, coordinating the direction of global review and regulation in the field of advanced biopharmaceuticals.

In addition, at a bilateral meeting with Indonesian Food and Drug Authority (BPOM), the two sides discussed cooperation on the stable supply of source plasma and, building on regulatory trust in the field of drug approval and review, Korea proposed being registered as a reference country for Indonesia, agreeing to continue working-level discussions to put this into practice.

Meanwhile, 1:1 meetings were held between global regulators from Canada, Japan, Singapore, Vietnam and Malaysia and Korean companies seeking to export, providing a venue to support exports by exploring overseas approval and licensing strategies.

Building on the network of cooperation with experts and regulatory authorities from Korea and abroad built through this year's GBC, MFDS plans to continue regulatory innovation in the biopharmaceutical field and to actively support Korean companies' entry into global markets.

MFDS also stated that it will continue to develop GBC into a leading international event for sharing innovative technologies and regulatory policy in the global biopharmaceutical field, and will make every effort so that the Republic of Korea can leap forward as a nation leading global biopharmaceutical regulation and industrial innovation.

SOURCE The Korea Herald

Share this article

Since launching in October 2025, Moonlock has taken a different approach to cybersecurity, reflected in every detail of the app. Its intuitive interface, plain-spoken copy, and hand-drawn illustrations replace the cold, technical tone common to security software. The result is a security app making protection feel easy and stress-free for everyone, expert or not.

Clear, human, beautiful products are a core MacPaw value, and the company pays attention to every detail, from aesthetics to user experience. Moonlock is no exception: it was built to make cybersecurity accessible to everyone, whatever their background — and design is central to that mission.

"Cybersecurity has a reputation for being intimidating — all alerts and jargon, with the sense that you need to be an expert just to stay safe. We built Moonlock to change that," said Oleg Stukalenko, Head of Product Management at Moonlock by MacPaw. "From the start, we wanted it to feel human and welcoming, so that online protection becomes a natural part of everyday life rather than something people worry about. We think of design as everything someone actually experiences with us, not just the screen in front of them. Having the Red Dot jury recognize that work means a lot to the whole team."

The Red Dot Award: Brands & Communication Design celebrates the craft behind how a product looks, feels, and speaks to the people who use it. Held since 1993, the competition is open to established and emerging designers, agencies, and companies across 18 categories. Each year, an international jury of 30 experts from design, science, media, and consultancy evaluates the entries, bringing a wide range of professional and cultural perspectives to every decision.

With this win, Moonlock continues MacPaw's legacy of design excellence. It is the company's fourth Red Dot Award: in 2017, Gemini 2 became the first macOS application to win the honor, followed by CleanMyMac in 2021 and CleanMy®Phone in 2024.

About Moonlock

Moonlock is a part of the MacPaw ecosystem that offers simple, approachable, and stress-free Mac protection and antivirus capabilities.

About MacPaw

MacPaw is a global technology company founded in Kyiv, Ukraine, with offices in Boston, MA and the EU, creating a digital ecosystem for Mac users. Combining capabilities such as system care, cybersecurity, app discovery, and more, the ecosystem aims to unite MacPaw's suite of software, third-party tools, and AI solutions to collaborate on behalf of the user. Through Eney, an AI-powered assistant and the interface of the ecosystem, MacPaw aims to help users and developers within their workflows, driving the next generation of human-computer interaction.

Contacts

[email protected] 

SOURCE MacPaw

Share this article